PubRank

Martin Messerle

Author PubWeight™ 52.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 2002 2.42
2 Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 2008 2.35
3 Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 2002 1.92
4 NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 2005 1.60
5 Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol 2005 1.46
6 Cloning of herpesviral genomes as bacterial artificial chromosomes. Rev Med Virol 2003 1.43
7 Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J Infect Dis 2003 1.28
8 The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med 2006 1.27
9 Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J Virol 2004 1.21
10 Nuclear egress and envelopment of herpes simplex virus capsids analyzed with dual-color fluorescence HSV1(17+). J Virol 2007 1.21
11 Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol 2005 1.21
12 Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. J Virol 2005 1.15
13 An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis. J Virol 2003 1.13
14 Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J Virol 2004 1.11
15 Elimination of ie1 significantly attenuates murine cytomegalovirus virulence but does not alter replicative capacity in cell culture. J Virol 2005 1.10
16 Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture. J Virol 2002 1.09
17 The human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUL56 and pUL89. J Virol 2012 1.08
18 The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J Gen Virol 2002 1.07
19 Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 2007 1.06
20 Conditional and reversible disruption of essential herpesvirus proteins. Nat Methods 2009 1.06
21 The essential human cytomegalovirus gene UL52 is required for cleavage-packaging of the viral genome. J Virol 2007 1.04
22 Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest 2010 1.04
23 Analysis of human cytomegalovirus oriLyt sequence requirements in the context of the viral genome. J Virol 2005 1.03
24 Single cell detection of latent cytomegalovirus reactivation in host tissue. J Gen Virol 2011 0.97
25 Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation. J Immunol 2013 0.96
26 Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer. J Virol 2006 0.96
27 The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cells. PLoS Pathog 2011 0.96
28 A redshifted codon-optimized firefly luciferase is a sensitive reporter for bioluminescence imaging. Photochem Photobiol Sci 2008 0.95
29 Identification of the interaction domain of the small terminase subunit pUL89 with the large subunit pUL56 of human cytomegalovirus. Biochemistry 2006 0.94
30 Use of bacterial artificial chromosomes in generating targeted mutations in human and mouse cytomegaloviruses. Curr Protoc Immunol 2007 0.94
31 Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes. J Virol 2011 0.93
32 Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes. J Virol 2003 0.92
33 Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus. Med Microbiol Immunol 2008 0.92
34 Mutagenesis of herpesvirus BACs by allele replacement. Methods Mol Biol 2004 0.87
35 Cloning of beta-herpesvirus genomes as bacterial artificial chromosomes. Methods Mol Biol 2004 0.86
36 Absence of Siglec-H in MCMV infection elevates interferon alpha production but does not enhance viral clearance. PLoS Pathog 2013 0.85
37 Construction of a cytomegalovirus-based amplicon: a vector with a unique transfer capacity. Hum Gene Ther 2003 0.85
38 Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1γ. Proc Natl Acad Sci U S A 2013 0.85
39 The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infection. J Virol 2010 0.84
40 A peptide inhibitor of cytomegalovirus infection from human hemofiltrate. Antimicrob Agents Chemother 2013 0.82
41 Tumor-specific activity of cellular regulatory elements is down-regulated upon insertion into the herpes simplex virus genome. J Neurovirol 2008 0.82
42 The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs. J Virol 2009 0.81
43 In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation. J Virol 2008 0.81
44 Cross-presentation of Listeria-derived CD8 T cell epitopes requires unstable bacterial translation products. J Immunol 2004 0.81
45 Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection. PLoS Pathog 2012 0.79
46 Cytomegalovirus immune evasion of myeloid lineage cells. Med Microbiol Immunol 2015 0.78
47 Novel DNA polymerase mutations conferring cytomegalovirus resistance: input of BAC-recombinant phenotyping and 3D model. Antiviral Res 2013 0.78
48 Use of recombinant approaches to construct human cytomegalovirus mutants. Methods Mol Biol 2014 0.76
49 Prolonged endoplasmic reticulum stress promotes mislocalization of immunoglobulins to the cytoplasm. Mol Immunol 2010 0.76
50 Genetic labeling reveals altered turnover and stability of innate lymphocytes in latent mouse cytomegalovirus infection. J Immunol 2011 0.75